Skip to main content

Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)

The Calu-6 (ATCC number HTB-56) epithelial cell line was derived from the tissue of a 61-year-old Caucasian female suffering from anaplastic carcinoma (lung cancer). The Calu-6 transfection cells are used for research models to further study human lung cancer and its leading pathways. Additionally, research on the relationship between animycin A (AMA) and lung cancer cells have also been conducted. Calu-6 transfection reagents enhance the intracellular delivery of oligonucleotides when the Calu-6 cell line is used as a transfection host. 

 Transfection Reagent for Calu-6 Cells (Lung Carcinoma Cell, HTB-56)
Labels:

Popular posts from this blog

Transfection and Xenograft Tools for Calu-6 From Altogen Biosystems

Altogen Biosystems is an international developer and laboratory for genetic research. Laboratory offers and additional experiments include IC-50 assays, toxicology assays, 28-day generation of stably-transfected cells, RNAi testing and more. Dedicated to aiding pharmaceutical companies with cutting-edge and specialized services, Altogen Biosystems ventures to optimize modern laboratory discoveries. Visit the catalog of xenograft models for a Calu-6 xenograft model .
Post a Comment
Read more

Calu-6 Cell Line

The Calu-6 cell line was established from the lung tissue of a 61-year-old Caucasian female who had been suffering from anaplastic carcinoma. Calu-6 cells are tumorigenic and have a modal chromosome number of 59. They also exhibit adherent cultural properties and display an epithelial morphology. The Calu-6 cell line is a suitable transfection host for in vivo and in vitro  methods to study lung cancer, and a Calu-6 Transfection Reagent  can be purchased through Altogen Biosystems  to transfect Calu-6 cells. A Calu-6 xenograft model can be found here . 
Post a Comment
Read more

The Role of Vandetanib in Calu-6 Cells

Vandetanib is a multikinase inhibitor that is a target of drug treatments for non-small cell lung cancer. In this study, researchers determine the cellular and biological effects of vandetanib on Calu-6 cells. Results showed that vandetanib inhibits Calu-6 cell migration and invasiveness. Vandetanib also induces autophagy in Calu-6 cells by increasing the level of reactive oxygen species (ROS). These findings show that vandetanib produces a double effect in some NSCLC cells, which presents vandetanib as a potential agent for treatment of Calu-6 cells. [ LINK ]
Post a Comment
Read more